Hormonal contraceptives have been associated with increased risk of HIV acquisition.
Methods
The association between hormonal contraception use and HIV acquisition was assessed in a rural community-based cohort in Rakai District, Uganda. A group of 5117 sexually active HIV-negative women were surveyed at 10 month intervals between 1994 and 1999. Information on demographic and sociobehavioral characteristics, use of hormonal contraception (pill and injectable methods), condoms and the number of sexual partners was obtained by home-based interview. HIV incidence rate ratios (IRR) and 95% confidence intervals (CI) associated with hormonal contraception were estimated by multivariate Poisson regression after adjustment for age, condom use, number of sexual partners, marital status, education and history of genital ulcer disease.
Results
At one or more interviews, 16.6% of women reported use of hormonal contraceptives and 23.0% reported condom use. HIV incidence was 2.3/100 person-years in hormonal contraceptive users compared with 1.5/100 person-years in non-hormonal contraceptive users (unadjusted IRR, 1.56; 95% CI, 1.00-2.33). After multivariate adjustment, the IRR associated with hormonal contraceptives was reduced to 0.94 (95% CI, 0.53-1.64). The adjusted IRR was 1.12 (95% CI, 0.48-2.56) with oral contraceptive use and 0.84 (95%CI, 0.41-1.72) with injectable methods.
Conclusion
Use of hormonal contraception is not associated with HIV acquisition after adjustment for behavioral confounding.
hormonal contraception hiv risk, oral contraceptives hiv acquisition, depot medroxyprogesterone hiv infection, injectable contraception hiv incidence, contraceptive pill hiv transmission, dmpa hiv risk women, hormonal birth control sexually transmitted infections, uganda cohort contraception hiv, condom use hiv prevention, behavioral confounding contraception hiv
Cite this article
Kiddugavu, M., Makumbi, F., Wawer, M. J., Serwadda, D., Sewankambo, N. K., Wabwire-Mangen, F., Lutalo, T., Meehan, M., Gray, R. H., Xianbin, & Rakai Project Study Group (2003). Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. *AIDS (London, England)*, *17*(2), 233-240. https://doi.org/10.1097/00002030-200301240-00014
Kiddugavu M, Makumbi F, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS. 2003;17(2):233-240. doi:10.1097/00002030-200301240-00014
Kiddugavu, Mohammed, et al. "Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda." *AIDS (London, England)*, vol. 17, no. 2, 2003, pp. 233-240.
Objective: This report presents national estimates of contraceptive use and method choice based on the 1982, 1995, and 2002 National Surveys of Family Growth (NSFG). It also presents data on where wom...
Objective: To evaluate the effect of oral and injectable hormonal contraception on the risk of HIV acquisition among women in South Africa and Zimbabwe.
Design: Secondary data analysis of 4913 sexuall...
Background: The evidence from epidemiological research into whether use of hormonal contraception increases women's risk of HIV acquisition is inconsistent. We did a robust meta-analysis of existing d...
Background: Combined oral contraceptives (COC) and depot-medroxyprogesterone acetate (DMPA) are among the most widely used family planning methods; their effect on HIV acquisition is not known.
Object...